An analysis by U.S. regulators says Johnson & Johnson's single-dose vaccine provides strong protection against severe COVID-19.
By Lauren Neergaard, Matthew Perrone, Associated Press
The FDA reviewers said that the two-dose vaccine “was highly effective” in preventing symptomatic COVID-19 from occurring “at least 14 days after the receipt of the second dose.”…
By Matthew Perrone, Lauran Neergaard, Associated Press
The test kit from an Australian company allows users to swab themselves and get the results at home in about 20 minutes.
By Matthew Perrone, Associated Press
The nation’s first COVID-19 vaccine will begin arriving in states Monday morning, U.S. officials said Saturday, after the government gave the final go-ahead to the shots needed to end an outbreak that has killed nearly 300,000 Americans.
By Lauran Neergaard, Jonathan Lemire and Catherine Lucey, Matthew Perrone, Associated Press
By Lauran Neergaard, Matthew Perrone, Associated Press
A U.S. government advisory panel has endorsed Pfizer's coronavirus vaccine, in a major step toward an epic vaccination campaign that could finally conquer the outbreak.
The Food and Drug Administration posted a positive review of the Pfizer vaccine on Tuesday and will hold a public hearing on Thursday. The Associated Press has a look at the process.
While much attention has been given to approving a COVID-19 vaccine, there's been little paid to the facilities where many vaccines are manufactured. A recent investigation in Vanity Fair features a former FDA inspector turned whistleblower who says that the…
By Colleen Long, Associated Press
The coronavirus vaccine inching toward approval in the U.S. is desperately anticipated by Americans longing for a path back to normal life. But criminals are waiting, too. They're ready to use that desperation to their advantage.
By Linda A. Johnson, Associated Press
Two drugmakers say they have the go-ahead to resuming U.S. testing of their COVID-19 vaccine candidates. Both are in the final stage of testing before the companies can seek regulatory approval.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.